Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Ampio Pharm stock
Learn how to easily invest in Ampio Pharm stock.
Ampio Pharm is a biotechnology business based in the US. Ampio Pharm shares (AMPE) are listed on the NYSE MKT and all prices are listed in US Dollars. Ampio Pharm employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Ampio Pharm stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – AMPE. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Ampio Pharm stock price (NYSE MKT: AMPE)Use our graph to track the performance of AMPE stocks over time.
Ampio Pharm shares at a glance
|Latest market close||$0.28|
|52-week range||$0.20 - $9.71|
|50-day moving average||$0.31|
|200-day moving average||$1.75|
|Wall St. target price||$2.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.12|
Buy Ampio Pharm stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Ampio Pharm stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ampio Pharm price performance over time
|1 week (2023-01-20)||5.00%|
|1 month (2022-12-27)||28.45%|
|3 months (2022-10-27)||845.00%|
|6 months (2022-07-27)||77.19%|
|1 year (2022-01-24)||-40.94%|
|2 years (2021-01-27)||-81.94%|
|3 years (2020-01-27)||0.692|
|5 years (2018-01-26)||2.72|
Ampio Pharm financials
|Gross profit TTM||$0|
|Return on assets TTM||-81.42%|
|Return on equity TTM||-130.71%|
|Market capitalisation||$4.1 million|
TTM: trailing 12 months
Ampio Pharm share dividends
We're not expecting Ampio Pharm to pay a dividend over the next 12 months.
Have Ampio Pharm's shares ever split?
Ampio Pharm's shares were split on a 1:15 basis on 9 November 2022. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ampio Pharm shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Ampio Pharm shares which in turn could have impacted Ampio Pharm's share price.
Ampio Pharm share price volatility
Over the last 12 months, Ampio Pharm's shares have ranged in value from as little as $0.199 up to $9.705. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Ampio Pharm's is 1.685. This would suggest that Ampio Pharm's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ampio Pharm overview
Ampio Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado. .
Ampio Pharm in the news
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
Frequently asked questionsWhat percentage of Ampio Pharm is owned by insiders or institutions?
Currently 7.506% of Ampio Pharm shares are held by insiders and 13.026% by institutions. How many people work for Ampio Pharm?
Latest data suggests 9 work at Ampio Pharm. When does the fiscal year end for Ampio Pharm?
Ampio Pharm's fiscal year ends in December. Where is Ampio Pharm based?
Ampio Pharm's address is: 373 Inverness Parkway, Englewood, CO, United States, 80112 What is Ampio Pharm's ISIN number?
Ampio Pharm's international securities identification number is: US03209T1097 What is Ampio Pharm's CUSIP number?
Ampio Pharm's Committee on Uniform Securities Identification Procedures number is: 03209T109
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert